Please try another search
Welby Inc. is mainly engaged in the provision of personal health record (PHR) platform service that supports patient self-management in the treatment of various diseases including lifestyle diseases such as diabetes and hypertension. The Company operates business aiming at establishing the PHR platform in the medical field. The Company provides disease solution service and Welby My Carte service. The disease solution service is the development of the PHR platform at the request of the pharmaceutical companies. The Welby My Carte service is a company-owned cloud service that supports self-management of patients' living habits, such as diabetes and hypertension, among others.
Name | Age | Since | Title |
---|---|---|---|
Takeru Hiki | - | 2011 | CEO & Representative Director |
Naoya Matsumoto | 50 | 2016 | Independent Outside Director |
Masakazu Nakajima | 50 | 2016 | Director |
Taro Ishibashi | 65 | 2018 | Independent Outside Director |
Takeshi Yamamoto | 56 | 2021 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review